December 05, 2017 | Cbonds
December 04, 2017 Valeant Pharmaceuticals International issued international bonds (USC94143AM30) with a 9% for USD 1,500.0m maturing in 2025. Bonds were sold at a price of 98.611% with an initial yield of 9.25%. Bookrunner: Barclays. Depository: Clearstream Banking S.A., Euroclear Bank.
|Status||Country of risk||Redemption (offer)||Volume||Emission Rating (M/S&P/F)|
Company: Valeant Pharmaceuticals International
|Full company name||Valeant Pharmaceuticals International Inc|
|Country of risk||Canada|
|Country of registration||Canada|